Completed Enrollment

A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) (SYNERGY-NASH)

The purpose of this study is to see if the study drug, tirzepatide administered once weekly, is safe and effective as a treatment for Nonalcoholic Steatohepatitis (NASH).

Trial Summary

Age Range
18 - 80 years
Conditions the trial is for
NASH (Nonalcoholic Steatohepatitis)
What the trial is testing?
tirzepatide (LY3298176)
Could I receive a Placebo?
Yes
Enrollment Goal
196
Trial Dates
Nov 19, 2019 - Feb 7, 2024
How long will I be in the trial?
The study will last about 68 weeks and may include up to 15 visits.
Trial Phase
II

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Participants must have a body mass index (BMI) 27 kilograms per square meter (kg/m²) and 50 kg/m² with stable body weight for at least 3 months

  • Participants with or without type 2 diabetes mellitus (T2DM). If the participant has T2DM, the hemoglobin A1c (HbA1c) 9.5%

  • Participants must be willing to undergo baseline and endpoint liver biopsies

  • Participants must have a liver biopsy that shows fatty liver with liver scarring

Participants Must Not:

  • Participants must not have known or suspected alcohol abuse (>14 units/week for women and >21 units/week for men) or active substance abuse

  • Participants must not have heart attack, stroke, or hospitalization for congestive heart failure in the past 6 months

  • Participants must not have active cancer within the last 5 years

  • Participants must not have a diagnosis of type 1 diabetes

  • Participants must not have a history of inflammation of the pancreas

  • Female participants must not be pregnant, breast-feeding, or intend to become pregnant or of childbearing potential and not using adequate birth control

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.

Clinical Trial Resources